Table I.
Summary of all literature-documented cases of PDD due to HPyV6 or HPyV7
| Case report | Age (Y)/Sex | Immune status | Clinical presentation | Treatments attempted | Outcome |
|---|---|---|---|---|---|
| Ho et al4 |
|
|
|
|
|
| Nguyen et al2 |
|
|
|
|
|
| Smith et al5 | 59/M | Bilateral lobar (living) transplant recipient on prednisone and tacrolimus | Diffuse, gray, lichenified plaques with confetti-like islands of sparing on the trunk and proximal extremities and generalized pruritus |
|
|
| Canavan et al3 | 48/M | Cardiac transplant recipient on sirolimus and tacrolimus | Severely pruritic, pink to gray macules, thin papules, and plaques on the trunk and extremities, sparing acral areas and the face | Cyproheptadine, doxepin, emollients, topical corticosteroids, parmoxine cream, intravenous cidofovir, and oral acitretin 25 mg | No improvement with topical treatments or antihistamines. Temporary improvement with intravenous cidofovir with subsequent relapse within 4-6 weeks. Complete clinical resolution with oral acitretin |
| Current report | 44/M | Kidney and pancreas transplant recipient on tacrolimus and everolimus | Hyperpigmented scaly patches all over body and prominent follicular spines on the elbows and palms | Oral acitretin 25 mg daily | Complete clearing of patches with improvement in keratotic papules at 1-month follow-up |
HPyV6, Human polyomavirus 6; HPyV7, human polyomavirus 7; PDD, pruritic and dyskeratotic dermatosis.